Trial · NCT06606327
Diazoxide Suppression Test P&F Study
NCT06606327, Phase 1, Terminated, Columbia University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Diazoxide Suppression Test P&F Study. Trials, record NCT06606327. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06606327
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Diazoxide Suppression Test P&F Study
- NCT number
- NCT06606327
- Status
- Terminated
- Phases
- Phase 1
- Enrollment
- 1 participants, actual
- Lead sponsor
- Columbia University
- Conditions
- Insulin Resistance, Hyperinsulinemia, Obesity
- Interventions
- Diazoxide, 3 mg/kg per dose
- First posted
- 2024-09-23
- Last updated
- 2026-08-07
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Fasting plasma glucose | Baseline and after 4 days of diazoxide treatment | Plasma glucose level after overnight fast (units: mg/dL) |
| Primary | Fasting serum insulin | Baseline and after 4 days of diazoxide treatment | Serum insulin level after overnight fast (units: µU/mL) |
| Secondary | Fasting serum C-peptide | Baseline and after 4 days of diazoxide treatment | Serum C-peptide level after overnight fast (units: ng/mL) |
| Secondary | Fasting serum triglyceride | Baseline and after 4 days of diazoxide treatment | Serum triglyceride level after overnight fast (units: mg/dL) |
| Secondary | Fasting plasma free fatty acids (FFA) | Baseline and after 4 days of diazoxide treatment | FFA level after overnight fast (units: mmol/L) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants3
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|---|---|---|---|---|---|
| K12DK133995 | Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs) | MAAHS, DAVID MATTHEW; DIMEGLIO, LINDA A | STANFORD UNIVERSITY | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2022 to 2025 | NIH RePORTER |
| K23DK140614 | Human Models of Selective Insulin Resistance | COOK, JOSHUA ROBERT | COLUMBIA UNIVERSITY HEALTH SCIENCES | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2025 | NIH RePORTER |
| P30DK063608 | Columbia Diabetes Research Center | PAJVANI, UTPAL; HAEUSLER, REBECCA ANNE | COLUMBIA UNIVERSITY HEALTH SCIENCES | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2003 to 2025 | NIH RePORTER |
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06606327
GET https://conductscience.org/api/trials/v1/NCT06606327/registered